UBS downgraded Healthways, Inc. shares from Neutral to Sell. However, the brokerage has boosted the price objective from $19 to $22.50.As the company has been restructuring, the stock jumped 100 percent in last 30 days. The lead analyst questioned whether the restructured firm could be in a position to deliver increased expectations from investors.via